Back
Collegium Pharmaceutical Quote, Financials, Valuation and Earnings
Buy
51
COLL
Collegium Pharmaceutical
Last Price:
33.99
Seasonality Move:
-1.07%
7 Day Trial
ALL ACCESS PASS
$
7
Collegium Pharmaceutical Price Quote
$33.99
+0.01 (+2.1%)
(Updated: May 16, 2024 at 6:01 AM ET)
Collegium Pharmaceutical Key Stats
Buy
51
Collegium Pharmaceutical (COLL)
is a Buy
Day range:
$33.30 - $34.81
52-week range:
$20.83 - $40.95
Dividend yield:
0%
P/E ratio:
26.34
P/S ratio:
2.82
P/B ratio:
5%
Volume:
1.1M
Avg. volume:
448.1K
1-year change:
44.6%
Market cap:
$1.1B
Revenue:
$566.8M
EPS:
$2.41
How Much Does Collegium Pharmaceutical Make?
-
How Much Are Collegium Pharmaceutical's Sales Annually?
COLL Revenues are $566.8M -
How Much Profit Does Collegium Pharmaceutical's Make A Year?
COLL net income is $48.2M
Is Collegium Pharmaceutical Growing As A Company?
-
What Is Collegium Pharmaceutical's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0% -
What Is Collegium Pharmaceutical's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Collegium Pharmaceutical Stock Price Performance
-
Did Collegium Pharmaceutical Stock Go Up Last Month?
Collegium Pharmaceutical share price went down by -3.3% last month -
Did COLL's Share Price Rise Over The Last Year?
COLL share price rose by 44.6% over the past 1 year
What Is Collegium Pharmaceutical 52-Week High & Low?
-
What Is Collegium Pharmaceutical’s 52-Week High Share Price?
Collegium Pharmaceutical has traded as high as $40.95 over the past 52 weeks -
What Is Collegium Pharmaceutical’s 52-Week Low Share Price?
Collegium Pharmaceutical has traded as low as $20.83 over the past 52 weeks
Collegium Pharmaceutical Price To Free Cash Flow
-
Is Collegium Pharmaceutical Stock Overvalued?
Collegium Pharmaceutical is trading at a price to free cash flow ratio of 5.18 -
Is Collegium Pharmaceutical Stock Undervalued?
Collegium Pharmaceutical EV to Free Cash Flow ratio is 4.60 -
What Is Collegium Pharmaceutical’s Price Earnings Growth Ratio?
COLL PEG ratio is 0.00 -
Is Collegium Pharmaceutical Trading At A Premium To Earnings?
Collegium Pharmaceutical EV to EBIT ratio is 6.77
Is It Risky To Buy Collegium Pharmaceutical?
-
How Much Debt Does Collegium Pharmaceutical Have?
Total long term debt quarterly is $623.1M -
How Much Cash Does Collegium Pharmaceutical Have?
Cash and short term investments quarterly total is $318M -
What Is Collegium Pharmaceutical’s Book Value Per Share?
Book value per share is 6.79
Is Collegium Pharmaceutical Cash Flow Positive?
-
What Is COLL Cash Flow From Operations?
Cash flow from operations (TTM) is $309M -
What Is Collegium Pharmaceutical’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$262.6M -
What Is Collegium Pharmaceutical’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$88.8M
Collegium Pharmaceutical Return On Invested Capital
-
Is Management Doing A Good Job?
COLL return on invested capital is 10.29% -
What Is Collegium Pharmaceutical Return On Assets?
ROA measures how assets are converting to revenues and is 7.96% -
What Is COLL Return On Equity?
ROE is a measure of profitability and is 47.75%
Collegium Pharmaceutical Earnings Date & Stock Price
-
What Is Collegium Pharmaceutical's Stock Price Today?
A single share of COLL can be purchased today for 33.98 -
What Is Collegium Pharmaceutical’s Stock Symbol?
Collegium Pharmaceutical trades on the nasdaq under the ticker symbol: COLL -
When Is Collegium Pharmaceutical’s Next Earnings Date?
The next quarterly earnings date for Collegium Pharmaceutical is scheduled on August 2, 2024 -
When Is COLL's next ex-dividend date?
Collegium Pharmaceutical's next ex-dividend date is May 16, 2024 -
How To Buy Collegium Pharmaceutical Stock?
You can buy Collegium Pharmaceutical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Collegium Pharmaceutical Competitors
-
Who Are Collegium Pharmaceutical's Competitors?
Below is a list of companies who compete with Collegium Pharmaceutical or are related in some way:
Collegium Pharmaceutical Dividend Yield
Data Unavailable
Collegium Pharmaceutical Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -1.36% |
| Revenue: | 0.11% | -1.37% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 4 |
| Sell Recommendations: | 0 |
| Price Target: | 40.00 |
| Upside from Last Price: | 17.72% |